HomeCompareSJRNF vs MRK

SJRNF vs MRK: Dividend Comparison 2026

SJRNF yields 1818.18% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SJRNF wins by $4103414683.78M in total portfolio value
10 years
SJRNF
SJRNF
● Live price
1818.18%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4103414683.84M
Annual income
$3,702,796,788,756,407.00
Full SJRNF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SJRNF vs MRK

📍 SJRNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSJRNFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SJRNF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SJRNF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SJRNF
Annual income on $10K today (after 15% tax)
$154,545.45/yr
After 10yr DRIP, annual income (after tax)
$3,147,377,270,442,946.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SJRNF beats the other by $3,147,377,270,434,617.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SJRNF + MRK for your $10,000?

SJRNF: 50%MRK: 50%
100% MRK50/50100% SJRNF
Portfolio after 10yr
$2051707341.95M
Annual income
$1,851,398,394,383,102.50/yr
Blended yield
90.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SJRNF
No analyst data
Altman Z
6.0
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SJRNF buys
0
MRK buys
0
No recent congressional trades found for SJRNF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSJRNFMRK
Forward yield1818.18%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4103414683.84M$56.8K
Annual income after 10y$3,702,796,788,756,407.00$9,798.13
Total dividends collected$4074760433.31M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SJRNF vs MRK ($10,000, DRIP)

YearSJRNF PortfolioSJRNF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$192,518$181,818.18$11,206$366.19+$181.3KSJRNF
2$3,477,331$3,271,336.99$12,650$502.35+$3.46MSJRNF
3$58,943,217$55,222,471.89$14,407$694.19+$58.93MSJRNF
4$937,891,469$874,822,227.57$16,585$967.82+$937.87MSJRNF
5$14,012,869,532$13,009,325,660.38$19,342$1,363.89+$14012.85MSJRNF
6$196,647,994,247$181,654,223,846.76$22,913$1,947.19+$196647.97MSJRNF
7$2,592,865,386,485$2,382,452,032,641.56$27,662$2,823.89+$2592865.36MSJRNF
8$32,132,661,421,271$29,358,295,457,731.54$34,159$4,173.35+$32132661.39MSJRNF
9$374,409,247,740,494$340,027,300,019,734.44$43,337$6,308.80+$374409247.70MSJRNF
10$4,103,414,683,838,736$3,702,796,788,756,407.00$56,776$9,798.13+$4103414683.78MSJRNF

SJRNF vs MRK: Complete Analysis 2026

SJRNFStock

ArcWest Exploration Inc. engages in the exploration of mineral properties in Canada. It primarily explores for copper and gold deposits. The company holds 100% interests in the Todd Creek property located in northeast of Stewart; the Oweegee Dome property that covers an area of 31,077 hectares located in east of Tudor Gold's Treaty Creek; the Oxide Peak property, which covers an area of 8,438 hectares located in the Toodoggone District; the Teeta Creek property located in northern Vancouver Island, British Columbia; and the Northern Vancouver Island property that covers an area of 6,884 hectares located in northern Vancouver. It also has interests in the Rip property, which covers an area of 7,811 hectares situated in south of Houston; Sparrowhawk project that covers an area of 9,913 hectares located in southeast of the Morrison Cu deposit; and the Eagle property covering an area of 2,530 hectares located in in northern Vancouver Island, British Columbia. The company was formerly known as Sojourn Exploration Inc. and changed its name to ArcWest Exploration Inc. in February 2019. ArcWest Exploration Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

Full SJRNF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SJRNF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SJRNF vs SCHDSJRNF vs JEPISJRNF vs OSJRNF vs KOSJRNF vs MAINSJRNF vs JNJSJRNF vs ABBVSJRNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.